FdaApplication
NDA 021259
Identifiers
- fda_app_no: NDA021259
Properties
| Property | Value |
|---|---|
| applicant_name | LANNETT COMPANY LLC |
| application_type | NDA |
| approval_date | 2001-04-03 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 40MG | CAPSULE, EXTENDED RELEASE;ORAL |
| METADATE CD | METHYLPHENIDATE HYDROCHLORIDE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
6 products